*By Jacqueline Corba*
Freshman Congressman Matt Gaetz (R-FL) is on a mission to pass a bill that would allow for expanded medical marijuana research.
"Research can demystify who is right and who is wrong," Gaetz told Cheddar's CannaBiz Tuesday. "It's kind of nice to let the science guide our policy making."
Last week, the [Medical Marijuana Act](https://gaetz.house.gov/media/press-releases/congressman-matt-gaetz-applauds-passage-medical-cannabis-bill-through-house) sponsored by Gaetz passed the U.S. House Judicial Committee with bipartisan support.
It's a "landmark moment" Gaetz said; it's the first time Republicans in control of Congress have passed a medical marijuana bill through committee. Next it will head to the House floor for a vote.
"I'm super excited about what potential cannabis has in healthcare, and I think we'll learn a lot more if we're not so stupid as a government to make the research illegal," Gaetz said.
The act would give research institutions "safe harbor" to study the potential uses, benefits, and risks of the drug, which remains a Schedule I classification under the federal law alongside heroin and LSD.
"I think that marijuana policy has in many ways been victimized by the overall chilled relationship between the White House and the Department of Justice," Gaetz said.
"I think it is really Jeff Sessions who opposes medical marijuana, and I'm not entirely sure he and President Trump will be on one another's Christmas lists going forward."
For Gaetz, Washington is obstructing its own view.
"Washington just needs to get out of the way so that we can really see the potential."
For full interview [click here](https://cheddar.com/videos/medical-cannabis-research-act-passes-first-hurdle-in-congress).
President Donald Trump says he has instructed aides to stop negotiating on another round of COVID-19 relief until after the election.
Federal Reserve Chair Jerome Powell warned Tuesday that a tentative recovery from the pandemic recession could falter unless the federal government supplies additional economic support.
The Food and Drug Administration has laid out its safety standards for developers of COVID-19 vaccines after the White House blocked their formal release.
President Donald Trump is back at the White House after staging a dramatic return from the military hospital where he has been receiving an unprecedented level of care for COVID-19.
President Donald Trump says he will leave the military hospital and return to the White House Monday evening.
Former Obama officials say that the protocols in place are up to the task of preserving the continuity of the U.S. government in the event President Trump may be incapacitated.
White House press secretary Kayleigh McEnany says she has tested positive for COVID 19 days after President Trump's diagnosis.
Two days after being hospitalized with COVID-19, President Donald Trump declared, “I get it,” in a message to the nation Sunday before briefly leaving the hospital to salute supporters from his motorcade.
President Donald Trump faces “critical” coming days after a “very concerning” period in his fight against COVID-19 at a military hospital, his chief of staff said Saturday — in contrast to a rosier assessment moments earlier by Trump doctors, who took pains not to reveal the president had received supplemental oxygen at the White House before his hospital admission.
President Donald Trump went through a “very concerning” period Friday and faces a “critical” next two days in his fight against COVID-19 at a military hospital, his chief of staff said Saturday — in contrast to a rosier assessment moments earlier by Trump doctors, who took pains not to reveal the president had received supplemental oxygen at the White House before his hospital admission.
